Écrit par ANSM | 18 Juin 2016

Lors de sa réunion mensuelle, qui s’est tenue du 6 au 9 juin à Londres, le Comité pour l’Evaluation des Risques en matière de Pharmacovigilance (PRAC) de l’Agence européenne des médicaments (EMA) a pris en compte le signal concernant le riociguat dans un essai clinique. Il a poursuivi la revue des données dans le cadre de l’arbitrage en cours pour les produits de contraste...

Écrit par WHO | 18 Juin 2016

GENEVA - 17 June 2016: The yellow fever vaccine given as one fifth of the regular dose could be used to control an outbreak in case of vaccine shortages.

Experts agreed with this proposal at a meeting convened by the World Health Organization (WHO) to consider potential shortages in yellow fever vaccine due to the outbreak in Angola and Democratic Republic of Congo.

WHO Strategic...

Écrit par WHO | 18 Juin 2016

17 June 2016 – The World Health Organization (WHO)/the Pan American Health Organization (PAHO) and partners have set out their strategic response to Zika which will place a greater focus on preventing and managing medical complications caused by Zika virus infection. To date, US$121.9 million are necessary to effectively implement the Zika Strategic Response Plan, July 2016 to December...

Écrit par WHO | 16 Juin 2016

Baghdad, 16 June 2016: WHO Regional Director for the Eastern Mediterranean Dr Ala Alwan arrived in Baghdad today to review firsthand WHO’s response to the unfolding humanitarian crisis in Fallujah city, where more than 42 000 Iraqis have been displaced since the beginning of the military operations in the city in May 2016. Tens of thousands of besieged and displaced men, women, children...